At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Coenzyme Q-10 in Pulmonary Hypertension subjects +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coenzyme Q-10 in the Treatment of Pulmonary Arterial Hypertension
In Brief
A clinical study evaluating Coenzyme Q-10 in Pulmonary Hypertension subjects and Coenzyme Q-10 in Normal Control subjects for Pulmonary Arterial Hypertension. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effects of Coenzyme Q-10, an antioxidant, in the treatment of pulmonary hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Arterial Hypertension
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
First PostedJun 2010
Primary CompletionJan 2014
TodayJul 2026
First PostedJun 22, 2010
Enrollment StartJan 1, 2010
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 16.0 years ago
Interventions
Coenzyme Q-10 in Pulmonary Hypertension subjectsdietary
Take 100mg Co-Q for three times daily
Coenzyme Q-10 in Normal Control subjectsdietary
Take 100mg Co-Q for three times daily